<DOC>
	<DOCNO>NCT00278070</DOCNO>
	<brief_summary>Patients recurrent metastatic solid tumor receive oral vinorelbine one three different dos ( 30 40 50 mg ) . Vinorelbine administer orally metronomic schedule three time week : Monday , Wednesday Friday .</brief_summary>
	<brief_title>Metronomic Oral Vinorelbine Patients With Metastatic Tumors</brief_title>
	<detailed_description>The purpose study define biologically optimal dose vinorelbine administer metronomic dosing schema . [ Metronomic chemotherapy refers close , regular administration minimally toxic dos cytotoxic drug , minimal drug-free break , prolong period ] . Patients recurrent metastatic solid tumor randomly assign one three different dos oral vinorelbine ( 30 40 50 mg ) . Treatment administer three time week ( Monday , Wednesday Friday ) continuously disease progression unacceptable toxicity maximum 24 month .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Signed informed consent Ages 16 75 year Genders : Performance status 02 accord World Health Organization ( WHO ) scale Life expectancy least 16 week Adequate bone marrow , hepatic renal function Absence brain metastasis Metastatic/locally advance refractory prostate , breast nonsmall cell lung cancer previously treat two chemotherapeutic regimen White blood cell &gt; = 3500/mm^3 Absolute neutrophil count &gt; = 1500/mm^3 Platelets &gt; = 100,000/mm^3 Total serum bilirubin le 1.5 mg/dl Serum transaminases less 2.0 x upper normal limit ( UNL ) unless attribute liver metastasis Serum creatinine within normal range Major active infection More two prior chemotherapy regimens metastatic disease Any follow within 12 month prior start study treatment : myocardial infarction , severe/unstable angina , coronary/peripheral artery bypass graft , congestive heart failure , cerebrovascular accident transient ischemic attack , pulmonary embolism , cardiac dysrhythmias grade &gt; /= 2 , atrial fibrillation grade , heart rate correct interval ( QTc ) &gt; 450 msec male &gt; 470 msec female . Hypertension control medication ( &gt; 150/100 mmHg despite optimal medical therapy ) Ongoing anticoagulation therapy Pregnancy breastfeed Other severe acute chronic medical psychiatric condition , laboratory abnormality would impart , judgment investigator , excess risk associate study participation study drug administration ; , judgment investigator , would make patient inappropriate entry trial .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Metronomic-therapy</keyword>
	<keyword>vinorelbine</keyword>
	<keyword>Recurrent Breast Cancer</keyword>
	<keyword>Recurrent Non Small Cell Lung Cancer</keyword>
	<keyword>Metastatic prostate cancer</keyword>
</DOC>